genengnews.com /4 weeks ago

Wirelessly Powered Electronic Implant, ECHO, Enables Drug-Free Management of ‘Diabesity’

Researchers developed an implantable, wirelessly powered electronic device, ECHO, that uses electrocatalysis to remove excess glucose from the bloodstream on demand, and could offe...

Read source
pharmexec.com /1 month ago

<![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

Read source
pharmexec.com /2 weeks ago

<![CDATA[ANI Pharmaceuticals to Acquire Egetis Therapeutics, Egetis Sells Priority Review Voucher for $190 Million]]&...

Read source
pharmexec.com /3 weeks ago

<![CDATA[ Pathos Ai Enters Drug Development Collaboration with Bristol Myers Squibb and Tempus Ai ]]>

Read source
prweb.com /2 weeks ago

BS PHARM KOREA Broadens Professional Aesthetic Offerings with Peptide and Organoid ECM Technologies

Following the October 2026 introduction of EVErECM and EVE ARI, the South Korean company expands its professional aesthetic portfolio with lab-grown organoid ECM and multi-peptide...

Read source
biopharmadive.com /2 days ago

Celldex drug stumbles in eczema; Epigenetic editing startup cuts staff

Wall Street analysts rushed to Celldex’s defense following the setback. Elsewhere, Isomorphic Labs cut a cancer-focused deal with Merck and Teva’s research chief accepted a new job...

Read source
pharmexec.com /1 month ago

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

Read source
labiotech.eu /1 week ago

Preclinical Pulse: The research catching our eye in November 2026 

Preclinical Pulse in November 2026 features research across therapeutic technologies, including small molecule and gene therapy approaches. The post Preclinical Pulse: The research...

Read source
e27.co /1 week ago

SeaX Ventures bets US$1.65M on Skribe Medical’s AI heart patch for cancer patients

Surviving cancer can come with a cruel footnote. Some of the therapies that shrink tumours can quietly weaken the heart. Clinicians call it cancer therapy-related cardiac dysfuncti...

Read source
channelnewsasia.com /4 weeks ago

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

Read source
newswire.com /4 days ago

DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partner...

Cooperation Between CLIA-Certified Cancer Diagnostics Laboratory and Canadian Tech-Bio Company Will Allow Artificial Intelligence Models to Interrogate World's Largest Primary Tumo...

Read source
seekingalpha.com /1 month ago

Sana Biotechnology: A Shot At Diabetes

Read source
newswire.com /1 week ago

Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update

Completes SYMON-II clinical study enrollment and advances clinical validation activities.Achieves critical manufacturing milestone ahead of contractual deadline, strengthening supp...

Read source
pharmexec.com /2 weeks ago

<![CDATA[Roundup: Boehringer Ingelheim Licenses Six Oncology Programs From Sino Biopharmaceutical, Nxera Licenses EP4...

Read source
qchron.com /1 month ago

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

SINGAPORE, Oct. 18, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), S...

Read source
newswire.com /1 week ago

Ensysce Biosciences Reports Third Quarter 2026 Financial Results and Business Highlights

~ Completed Acquisition of Cy Biopharma, Adding Lead Pipeline Asset CY200 for Complex Regional Pain Syndrome ~~ Submitted Phase 2a Protocol for CY200 to the UK's Medicines and Heal...

Read source
newswire.com /1 month ago

NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference

Company highlights ongoing clinical developments in traumatic brain injury (TBI) therapeutics and non-invasive cancer screening, sparking key vendor collaboration discussions.

Read source
graphene-info.com /3 weeks ago

Hawkeye Bio’s graphene-biosensor lung cancer blood test LEAP becomes commercially available

Hawkeye Bio and HealthQuest Esoterics, a clinical reference laboratory in Irvine, California, have announced the commercial availability of LEAP (Lung Enzyme Activity Profile), a p...

Read source
pharmexec.com /2 days ago

<![CDATA[Innogen Licenses GLP-1 Therapy Efsubaglutide Alfa to Arcera]]>

Read source
labiotech.eu /2 weeks ago

From gene editing to RNA therapies: The biotech trends to look out for at AHA Scientific Sessions 2026

We look at some of the key biotech developments, companies, and clinical data to watch at AHA Scientific Sessions 2026. The post From gene editing to RNA therapies: The biotech tre...

Read source
pharmexec.com /3 weeks ago

<![CDATA[Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb]]>

Read source
newswire.com /1 week ago

Pace Life Sciences Joins ARPA-H GIVE Program to Advance Individualized RNA Medicine Manufacturing

Supporting the Centillion-led team, Pace® will help the design, development and manufacturing rollout of an integrated platform built for patients with rare and ultra-rare genetic...

Read source
pharmexec.com /3 weeks ago

<![CDATA[Roundup: Astellas Licenses IL-12 Fusion Protein From Audax in Deal Worth Up to $1.34 Billion, EVERSANA Acqui...

Read source
techcrunch.com /1 month ago

Efferon wants to eradicate the devastating toll of pediatric sepsis

This Battlefield 200 startup has developed blood-purification tech to save children

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.